IDiyas

For the Inventor, By the Inventor

Princeton Junction, NJ, United States of America

Jerrold M Liesch

USPTO Granted Patents = 29

Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 309(Granted Patents)


Location History:

  • Princeton Junction, ES (1996)
  • Princeton Junction, NJ (US) (1984 - 1998)

Company Filing History:

goldMedal29 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1984-1998

Loading Chart...
29 patents (USPTO):
1. 5770587 - Antifungal agents (1998-06-23),
2. 5756472 - Antifungal agent obtained from hormonema (1998-05-26),
3. 5712109 - Antifungal agent produced by arthrinium arundinis ATCC 74359 (1998-01-27),
4. 5543429 - Antifungal agents (1996-08-06),
5. 5411985 - Gamma-pyrone-3-acetic acid as an inhibitor or interleukin-1 .beta. (1995-05-02),
6. 5366880 - Antibiotic agent (1994-11-22),
7. 5306708 - Antibiotic agent (1994-04-26),
8. 5290804 - Anthelmintic milbemycin analogs of novel microorganisms (1994-03-01),
9. 5233062 - Antibiotic eicosenoic acids (1993-08-03),
10. 5202309 - Antibiotic cyclopeptide fermentation product (1993-04-13),
11. 5130445 - Antifungal substances and process for their production (1992-07-14),
12. 5096923 - Novel squalene synthetase inhibitors (1992-03-17),
13. 5095003 - Oxytocin and vasopressin antagonists (1992-03-10),
14. 5093338 - Lipophilic macrolide useful as an immunosuppressant (1992-03-03),
15. 5091389 - Lipophilic macrolide useful as an immunosuppressant (1992-02-25),

Title: Exploring the Innovations of Inventor Jerrold M Liesch

Introduction:

Jerrold M Liesch, a prolific inventor based in Princeton Junction, NJ (US), has made significant contributions to the field of antifungal agents. With an impressive portfolio of 29 patents, Liesch's work at Merck & Company, Inc. has garnered recognition for its innovative approach to combating fungal infections.

Latest Patents:

Among Liesch's latest patents are groundbreaking discoveries in the realm of antifungal agents. His formulations, such as those derived from hormonema, have proven to exhibit potent antifungal activity. These novel compounds represent a promising avenue in the ongoing battle against fungal pathogens.

Career Highlights:

Throughout his career, Liesch has demonstrated a keen aptitude for inventing novel solutions to complex challenges. His tenure at Merck & Company, Inc. has been marked by a relentless pursuit of innovation, resulting in the successful development of multiple patent-worthy inventions. Liesch's 29 patents attest to his remarkable creativity and technical acumen in the pharmaceutical industry.

Collaborations:

In his pursuits, Liesch has collaborated closely with esteemed colleagues such as Otto D Hensens and Robert E Schwartz. Together, they have combined their expertise to push the boundaries of antifungal research, yielding impactful discoveries that have the potential to transform the landscape of medical treatments for fungal infections. The collaborative efforts of Liesch and his coworkers underscore the value of teamwork in driving innovation forward.

Conclusion:

In conclusion, Jerrold M Liesch stands as a pioneering inventor whose contributions to the field of antifungal agents have left an indelible mark on the industry. With a wealth of patents to his name and a steadfast commitment to innovation, Liesch continues to shape the future of pharmaceuticals through his groundbreaking research. His work serves as a testament to the power of ingenuity and perseverance in advancing scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…